Indianapolis-based Indiana University Health has become the first health system in the U.S. to administer Pixclara, a newly FDA-approved brain cancer imaging drug. The drug is approved for use in adults and children with suspected recurrent glioma, according to an…
The Latest
In this episode, Ashley Shearer, VP, Care Coordination, Patient Flow, The Queen’s Medical Center, and Bree Bush, General Manager, CareIntellect, GE HealthCare, discuss improving patient flow, breaking down operational silos, and using real-time data and predictive tools to support capacity…
Fort Wayne, Ind.-based Parkview Health’s MyChart patient portal remains unavailable after the health system took its network offline in response to suspicious activity. In an Oct. 19 Facebook update, Parkview said it was experiencing a systemwide internet outage that had…
The planned transfer of Mercy Medical Center to Baystate Health, both in Springfield, Mass., remains on schedule for Nov. 1, pending regulatory approval, a spokesperson for Hartford, Conn.-based Trinity Health of New England told Becker’s Oct. 19. Under the proposed…
Several hospital and health system CEOs have left their roles in 2026 less than a year after taking the helm. Becker’s reported more than 160 hospital and health system CEO exits between Jan. 8 and Oct. 8, including about 65…
Frank Devocelle, who previously served as president and CEO of Olathe (Kan.) Health, died Oct. 13 at age 79. Mr. Devocelle retired in 2018 after serving as CEO since 1975, ending a 47-year career with the organization. He was an…
Baton Rouge, La.-based FMOL Health has named David Worthy as vice president of revenue cycle for Franciscan Health Physicians, the health system’s employed provider group, according to a post on his LinkedIn page. Mr. Worthy most recently served as a…
Primary care clinicians at Corvallis, Ore.-based Samaritan Health Services have voted to join Northwest Medicine United, an AFT Healthcare affiliate, according to a union news release shared with Becker’s. The union said it will represent about 120 physicians, nurse practitioners…
The FDA has granted accelerated approval to an immunotherapy that may spare some patients with locally advanced rectal cancer from undergoing chemotherapy, radiation and surgery. The approval covers London-based GSK’s dostarlimab-gxly — sold under the brand name Jemperli — as…
The nasal vestibule is a primary reservoir for potential bacterial pathogens, including multidrug-resistant organisms (MDROs), and colonization is associated with an increased risk of healthcare-associated infections (HAIs). Most patients meet at least one criterion that puts them at risk for…
Presented by:
